German Health Insurers Warn Against Concessions on Austerity Plans

Germany's statutory health insurance association (GKV) has issued a strong warning to the ruling coalition, urging them not to back down on planned austerity measures within the healthcare system. The GKV leadership expressed concern that ongoing discussions could lead to concessions, particularly regarding planned savings from the pharmaceutical industry and medical practices, potentially diluting a crucial hospital reform.

“

Currently, much is being discussed about whether planned savings from the pharmaceutical industry and medical practices will be reversed and there is a threat that the hospital reform will be watered down.

Oliver Blatt, head of the GKV, stated in an interview with Neue Osnabrücker Zeitung that deviating from the planned savings would be a mistake, inevitably making healthcare more expensive for everyone in the long run. He emphasized that without bold and extensive reforms, rising health insurance contributions would be unavoidable. Blatt highlighted that in the first months of the year, health insurance expenditures grew twice as fast as revenues, warning of severe financial consequences if swift and decisive action is not taken by year-end.

“

This would be exactly the wrong way, because in the end it will become more expensive for everyone again.

The proposed austerity package, amounting to €18.8 billion, is slated for parliamentary approval next week. Its primary goal is to alleviate the financial burden on statutory health insurers in 2027 and prevent further increases in contributions. Measures include capping the rise in remuneration for doctors' offices, clinics, and the pharmaceutical sector, requiring patients to pay more for medications, and restricting the free co-insurance of spouses.

“

If not acted upon quickly and decisively, the finances will blow up in our faces at the turn of the year.

Despite the government's aims, the reform faces significant opposition from the healthcare sector, pharmaceutical companies, and patient advocacy groups. Doctors' associations have cautioned that the cuts could force them to reduce their service offerings. Blatt urged lawmakers to resist what he described as "lobby pressure" from these groups, asserting that insured individuals and employers have already contributed their fair share through increased supplementary contributions and planned adjustments to contribution ceilings.

“

that the Bundestag withstands the lobby pressure from the pharmaceutical industry, hospitals, and medical practices.